UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis

Proceedings of the National Academy of Sciences - PNAS, 2011-02, Vol.108 (6), p.2462-2467

2011

Volltextzugriff (PDF)

Body Mass Index and Age Affect Maximum Mouth Opening in a Contemporary American Population

Journal of oral and maxillofacial surgery, 2020-11, Vol.78 (11), p.1926-1932

2020

Volltextzugriff (PDF)

Varied Photon Radiation Sources Produce Differences in Cellular Response

Radiation research, 2023-04, Vol.199 (4), p.422

2023

Volltextzugriff (PDF)

Abstract 377: RON receptor tyrosine kinase in head and neck cancer: a potential target for overcoming resistance to anti-EGFR therapy

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.377-377

2023

Volltextzugriff (PDF)

Combination of Ionizing Radiation with Glutaminase Inhibition Improves Treatment Response in Head and Neck Squamous Cell Carcinoma

The FASEB journal, 2019-04, Vol.33 (S1), p.495.9-495.9

2019

Volltextzugriff (PDF)

Abstract S02-03: SARS-CoV-2 induces inflammatory cytokine release, which may be exacerbated by immune checkpoint blockade

Clinical cancer research, 2020-09, Vol.26 (18_Supplement), p.S02-S02-03

2020

Volltextzugriff (PDF)

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma

Clinical cancer research, 2022-04, Vol.28 (7), p.1345-1352

2022

Volltextzugriff (PDF)

Abstract A12: Metformin treatment in LAHNSCC induces an antitumorigenic immune response

Clinical cancer research, 2020-06, Vol.26 (12_Supplement_2), p.A12-A12

2020

Volltextzugriff (PDF)

Abstract A32: Targeting RON-mediated metabolic vulnerabilities in recurrent/progressive breast cancer

Cancer research (Chicago, Ill.), 2020-06, Vol.80 (11_Supplement), p.A32-A32

2020

Volltextzugriff (PDF)

Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial

Clinical cancer research, 2023-05, Vol.29 (10), p.1906-1915

2023

Volltextzugriff (PDF)

Abstract 2832: Plk1 signaling as a therapeutic target for HPV- head and neck cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2832-2832

2023

Volltextzugriff (PDF)

Preliminary effects on the innate immune system with the combination of cetuximab and durvalumab in metastatic/ relapsed head and neck squamous cell carcinoma in a phase II trial

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14273-e14273

2019

Volltextzugriff (PDF)

Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

Clinical cancer research, 2022-08, Vol.28 (16), p.3464-3472

2022

Volltextzugriff (PDF)

Abstract 2096: Natural killer cells inhibit CD4+ T cell mediated IL-9 production in head and neck Cancer

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2096-2096

2022

Volltextzugriff (PDF)

Abstract 6062: Radiosensitizing head and neck squamous cell carcinoma using isothiocyanates

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.6062-6062

2022

Volltextzugriff (PDF)

Abstract PO-094: Glutaminase inhibition increases ionizing radiation induced oxidative stress and DNA damage in head and neck squamous cell carcinoma models

Clinical cancer research, 2021-04, Vol.27 (8_Supplement), p.PO-094-PO-094

2021

Volltextzugriff (PDF)

Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer

Cancer, 2020-01, Vol.126 (2), p.354-362

2020

Volltextzugriff (PDF)

Assessing the Reliability and Positive Predictive Value of p16 as a Surrogate for Human Papillomavirus-Mediated E6/7 mRNA Expression in Squamous Cell Carcinoma of the Anal Canal

Diseases of the colon & rectum, 2021-04, Vol.64 (4), p.459-465

2021

Volltextzugriff (PDF)

Abstract 6278: Glutaminase inhibition in combination with ionizing radiation improves treatment response in head and neck squamous cell carcinoma models

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6278-6278

2020

Volltextzugriff (PDF)

Incidence of hypothyroidism in head and neck squamous cell carcinoma patients receiving radiotherapy with and without immune checkpoint inhibitors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e18551-e18551

2020

Volltextzugriff (PDF)

Impact of metformin on survival and mTOR pathway in head and neck cancer patients: An updated analysis

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e17500-e17500

2017

Volltextzugriff (PDF)

Phase 2 trial of adjuvant nivolumab following salvage resection in patients with recurrent squamous cell carcinoma of the head and neck

Clinical cancer research, 2022-08, Vol.28 (16), p.3464-3472

2022

Volltextzugriff (PDF)

Phase 2 pilot trial of RRx-001 as an anti-mucositis agent in patients with head and neck cancer treated with chemoradiation (PREVLAR)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.6078-6078

2022

Volltextzugriff (PDF)

Metformin treatment of locally advanced head and neck squamous cell carcinoma (LAHNSCC) patients induces an anti-tumorigenic immune response

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.6037-6037

2019

Volltextzugriff (PDF)

Single-cell multiplexed proteomics to identify novel polyfunctional CD8+ T cell signatures induced by nivolumab in head and neck cancer patients after salvage surgery

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6576-6576

2020

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis

Body Mass Index and Age Affect Maximum Mouth Opening in a Contemporary American Population

Varied Photon Radiation Sources Produce Differences in Cellular Response

Abstract 377: RON receptor tyrosine kinase in head and neck cancer: a potential target for overcoming resistance to anti-EGFR therapy

Combination of Ionizing Radiation with Glutaminase Inhibition Improves Treatment Response in Head and Neck Squamous Cell Carcinoma

Abstract S02-03: SARS-CoV-2 induces inflammatory cytokine release, which may be exacerbated by immune checkpoint blockade

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma

Abstract A12: Metformin treatment in LAHNSCC induces an antitumorigenic immune response

Abstract A32: Targeting RON-mediated metabolic vulnerabilities in recurrent/progressive breast cancer

Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial

Abstract 2832: Plk1 signaling as a therapeutic target for HPV- head and neck cancer

Preliminary effects on the innate immune system with the combination of cetuximab and durvalumab in metastatic/ relapsed head and neck squamous cell carcinoma in a phase II trial

Phase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

Abstract 2096: Natural killer cells inhibit CD4+ T cell mediated IL-9 production in head and neck Cancer

Abstract 6062: Radiosensitizing head and neck squamous cell carcinoma using isothiocyanates

Abstract PO-094: Glutaminase inhibition increases ionizing radiation induced oxidative stress and DNA damage in head and neck squamous cell carcinoma models

Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer

Assessing the Reliability and Positive Predictive Value of p16 as a Surrogate for Human Papillomavirus-Mediated E6/7 mRNA Expression in Squamous Cell Carcinoma of the Anal Canal

Abstract 6278: Glutaminase inhibition in combination with ionizing radiation improves treatment response in head and neck squamous cell carcinoma models

Incidence of hypothyroidism in head and neck squamous cell carcinoma patients receiving radiotherapy with and without immune checkpoint inhibitors

Impact of metformin on survival and mTOR pathway in head and neck cancer patients: An updated analysis

Phase 2 trial of adjuvant nivolumab following salvage resection in patients with recurrent squamous cell carcinoma of the head and neck

Phase 2 pilot trial of RRx-001 as an anti-mucositis agent in patients with head and neck cancer treated with chemoradiation (PREVLAR)

Metformin treatment of locally advanced head and neck squamous cell carcinoma (LAHNSCC) patients induces an anti-tumorigenic immune response

Single-cell multiplexed proteomics to identify novel polyfunctional CD8+ T cell signatures induced by nivolumab in head and neck cancer patients after salvage surgery

Aktive Filter

Suchergebnisse filtern